Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma

Donna E. Reece, Esther Masih-Khan, Eshetu G. Atenafu, Victor H. Jimenez-Zepeda, Peter Anglin, Christine Chen, Vishal Kukreti, Joseph R. Mikhael, Suzanne Trudel

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences